167 related articles for article (PubMed ID: 38293926)
1. Estimated Glomerular Filtration Rate and Implantable Cardioverter-Defibrillator in Nonischemic Systolic Heart Failure: Extended Follow-Up of DANISH.
Doi SN; Thune JJ; Nielsen JC; Haarbo J; Videbæk L; Yafasova A; Bruun NE; Gustafsson F; Eiskjær H; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Køber L; Butt JH
J Am Heart Assoc; 2024 Feb; 13(3):e031977. PubMed ID: 38293926
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Implantable Cardioverter Defibrillator in Nonischemic Systolic Heart Failure According to Sex: Extended Follow-Up Study of the DANISH Trial.
Butt JH; Yafasova A; Elming MB; Dixen U; Nielsen JC; Haarbo J; Videbæk L; Korup E; Bruun NE; Eiskjær H; Brandes A; Thøgersen AM; Gustafsson F; Egstrup K; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Thune JJ; Køber L
Circ Heart Fail; 2022 Sep; 15(9):e009669. PubMed ID: 35942877
[TBL] [Abstract][Full Text] [Related]
3. NT-proBNP and ICD in Nonischemic Systolic Heart Failure: Extended Follow-Up of the DANISH Trial.
Butt JH; Yafasova A; Elming MB; Dixen U; Nielsen JC; Haarbo J; Videbæk L; Korup E; Bruun NE; Eiskjær H; Brandes A; Thøgersen AM; Gustafsson F; Egstrup K; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Thune JJ; Køber L
JACC Heart Fail; 2022 Mar; 10(3):161-171. PubMed ID: 35241243
[TBL] [Abstract][Full Text] [Related]
4. New York Heart Association functional class and implantable cardioverter-defibrillator in non-ischaemic heart failure with reduced ejection fraction: Extended follow-up of the DANISH trial.
Karacan MN; Doi SN; Yafasova A; Thune JJ; Nielsen JC; Haarbo J; Bruun NE; Gustafsson F; Eiskjær H; Hassager C; Svendsen JH; Høfsten DE; Pehrson S; Køber L; Butt JH
Eur J Heart Fail; 2024 Jun; 26(6):1423-1431. PubMed ID: 38733253
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Follow-Up of DANISH (The Danish Study to Assess the Efficacy of ICDs in Patients With Nonischemic Systolic Heart Failure on Mortality).
Yafasova A; Butt JH; Elming MB; Nielsen JC; Haarbo J; Videbæk L; Olesen LL; Steffensen FH; Bruun NE; Eiskjær H; Brandes A; Thøgersen AM; Egstrup K; Gustafsson F; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Thune JJ; Køber L
Circulation; 2022 Feb; 145(6):427-436. PubMed ID: 34882430
[TBL] [Abstract][Full Text] [Related]
6. Right Ventricular Dysfunction and the Effect of Defibrillator Implantation in Patients With Nonischemic Systolic Heart Failure.
Elming MB; Hammer-Hansen S; Voges I; Nyktari E; Raja AA; Svendsen JH; Pehrson S; Signorovitch J; Køber LV; Prasad SK; Thune JJ
Circ Arrhythm Electrophysiol; 2019 Mar; 12(3):e007022. PubMed ID: 30866666
[TBL] [Abstract][Full Text] [Related]
7. Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure.
Elming MB; Nielsen JC; Haarbo J; Videbæk L; Korup E; Signorovitch J; Olesen LL; Hildebrandt P; Steffensen FH; Bruun NE; Eiskjær H; Brandes A; Thøgersen AM; Gustafsson F; Egstrup K; Videbæk R; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Køber L; Thune JJ
Circulation; 2017 Nov; 136(19):1772-1780. PubMed ID: 28877914
[TBL] [Abstract][Full Text] [Related]
8. Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease.
Bansal N; Szpiro A; Reynolds K; Smith DH; Magid DJ; Gurwitz JH; Masoudi F; Greenlee RT; Tabada GH; Sung SH; Dighe A; Go AS
JAMA Intern Med; 2018 Mar; 178(3):390-398. PubMed ID: 29404570
[TBL] [Abstract][Full Text] [Related]
9. The effect of implantable cardioverter-defibrillator in patients with diabetes and non-ischaemic systolic heart failure.
Rørth R; Thune JJ; Nielsen JC; Haarbo J; Videbæk L; Korup E; Signorovitch J; Bruun NE; Eiskjær H; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Køber L; Kristensen SL
Europace; 2019 Aug; 21(8):1203-1210. PubMed ID: 31323662
[TBL] [Abstract][Full Text] [Related]
10. Duration of Heart Failure and Effect of Defibrillator Implantation in Patients With Nonischemic Systolic Heart Failure.
Elming MB; Thøgersen AM; Videbæk L; Bruun NE; Eiskjær H; Haarbo J; Egstrup K; Gustafsson F; Hastrup Svendsen J; Høfsten DE; Pehrson S; Nielsen JC; Køber L; Thune JJ
Circ Heart Fail; 2019 Sep; 12(9):e006022. PubMed ID: 31500444
[TBL] [Abstract][Full Text] [Related]
11. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials.
Pun PH; Al-Khatib SM; Han JY; Edwards R; Bardy GH; Bigger JT; Buxton AE; Moss AJ; Lee KL; Steinman R; Dorian P; Hallstrom A; Cappato R; Kadish AH; Kudenchuk PJ; Mark DB; Hess PL; Inoue LY; Sanders GD
Am J Kidney Dis; 2014 Jul; 64(1):32-9. PubMed ID: 24518128
[TBL] [Abstract][Full Text] [Related]
12. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.
Nakhoul GN; Schold JD; Arrigain S; Harb SC; Jolly S; Wilkoff BL; Nally JV; Navaneethan SD
Clin J Am Soc Nephrol; 2015 Jul; 10(7):1119-27. PubMed ID: 26111859
[TBL] [Abstract][Full Text] [Related]
13. Risk Models for Prediction of Implantable Cardioverter-Defibrillator Benefit: Insights From the DANISH Trial.
Kristensen SL; Levy WC; Shadman R; Nielsen JC; Haarbo J; Videbæk L; Bruun NE; Eiskjær H; Wiggers H; Brandes A; Thøgersen AM; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Signorovitch J; Køber L; Thune JJ
JACC Heart Fail; 2019 Aug; 7(8):717-724. PubMed ID: 31302052
[TBL] [Abstract][Full Text] [Related]
14. Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure.
Køber L; Thune JJ; Nielsen JC; Haarbo J; Videbæk L; Korup E; Jensen G; Hildebrandt P; Steffensen FH; Bruun NE; Eiskjær H; Brandes A; Thøgersen AM; Gustafsson F; Egstrup K; Videbæk R; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S;
N Engl J Med; 2016 Sep; 375(13):1221-30. PubMed ID: 27571011
[TBL] [Abstract][Full Text] [Related]
15. Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators.
Bansal N; Szpiro A; Masoudi F; Greenlee RT; Smith DH; Magid DJ; Gurwitz JH; Reynolds K; Tabada GH; Sung SH; Dighe A; Cassidy-Bushrow A; Garcia-Montilla R; Hammill S; Hayes J; Kadish A; Sharma P; Varosy P; Vidaillet H; Go AS
Heart; 2017 Apr; 103(7):529-537. PubMed ID: 27742796
[TBL] [Abstract][Full Text] [Related]
16. Impact of signal-averaged electrocardiography findings on appropriate shocks in prophylactic implantable cardioverter defibrillator patients with nonischemic systolic heart failure.
Nomoto M; Suzuki A; Shiga T; Shoda M; Hagiwara N
BMC Cardiovasc Disord; 2022 Aug; 22(1):374. PubMed ID: 35974317
[TBL] [Abstract][Full Text] [Related]
17. Competing risks in patients with primary prevention implantable cardioverter-defibrillators: Global Electrical Heterogeneity and Clinical Outcomes study.
Waks JW; Haq KT; Tompkins C; Rogers AJ; Ehdaie A; Bender A; Minnier J; Dalouk K; Howell S; Peiris A; Raitt M; Narayan SM; Chugh SS; Tereshchenko LG
Heart Rhythm; 2021 Jun; 18(6):977-986. PubMed ID: 33684549
[TBL] [Abstract][Full Text] [Related]
18. Effect of Implantable Cardioverter-defibrillators in Nonischemic Heart Failure According to Background Medical Therapy: Extended Follow-up of the DANISH Trial.
Yafasova A; Doi SN; Thune JJ; Nielsen JC; Haarbo J; Bruun NE; Gustafsson F; Eiskjær H; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Køber L; Butt JH
J Card Fail; 2024 May; ():. PubMed ID: 38750689
[TBL] [Abstract][Full Text] [Related]
19. Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease.
Hess PL; Hellkamp AS; Peterson ED; Sanders GD; Al-Khalidi HR; Curtis LH; Hammill BG; Pun PH; Curtis JP; Anstrom KJ; Hammill SC; Al-Khatib SM
Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):793-9. PubMed ID: 25038119
[TBL] [Abstract][Full Text] [Related]
20. Risk of death without appropriate defibrillator shock in patients with advanced renal dysfunction.
Goldenberg I; Mor T; Nof E; Younis A; Berkovitch A; Rosso R; Barsheshet A; Suleiman M; Beinart R
Europace; 2019 Mar; 21(3):459-464. PubMed ID: 30689821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
